5-Cyclotetradecen-1-one, 3-methyl-, (5E)- | 1117765-92-0

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 5-Cyclotetradecen-1-one, 3-methyl-, (5E)-
• 英文别名: (5E)-3-methylcyclotetradec-5-en-1-one
• CAS: 1117765-92-0；259854-70-1
• 化学式: C₁₅H₂₆O
• 分子量: 222.37
• InChiKey: ZFGBKXBPHOUSJX-VQHVLOKHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.9
• 重原子数：
  16
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• [EN] ORGANIC COMPOUNDS<br/>[FR] COMPOSÉS ORGANIQUES
  申请人：GIVAUDAN SA

  公开号：WO2014207205A1

  公开（公告）日：2014-12-31

  Meta-Substituted 3-phenylpropanal derivatives useful in providing watery-marine, floral- aldehydic notes.

  甲基取代的3-苯丙醛衍生物可用于提供水性海洋、花香醛调。
• 3-METHYL-6-CYCLOHEXADECEN-1-ONE AND ITS USE IN PERFUME COMPOSITIONS
  申请人：Narula Anubhav P.S.

  公开号：US20130052151A1

  公开（公告）日：2013-02-28

  The present invention is directed to a novel compound, 3-methyl-cyclohexadec-6-enone, and a method of improving, enhancing or modifying a fragrance formulation through the addition of an olfactory acceptable amount of 3-methyl-cyclohexadec-6-enone.

  本发明涉及一种新颖的化合物3-甲基-环己十六烯酮，以及一种通过添加3-甲基-环己十六烯酮的嗅觉可接受量来改善、增强或修改香精配方的方法。
• 2,3,3-Trimethylcyclopent-3-Enecarbaldehyde Derivatives Useful as Odorants
  申请人：Bajgrowicz Jerzy A.

  公开号：US20100105782A1

  公开（公告）日：2010-04-29

  Described are 2,2,3-trimethylcyclopent-3-enecarbaldehyde derivatives of formula (I) wherein R 1 -R 7 have the same meaning as given in the specification. The invention furthermore relates to a method of their production and to fragrance compositions comprising them.

  描述了式(I)的2,2,3-三甲基环戊-3-烯甲醛衍生物，其中R1-R7的含义与规范中给出的相同。此外，本发明还涉及它们的生产方法以及包含它们的香精组合物。
• [EN] A PRODRUG COMPRISING BETA-KETO CARBOXYLIC ACID, BETA-KETO CARBOXYLIC ACID SALT OR BETA-KETO CARBOXYLIC ACID ESTER FOR DRUG DELIVERY<br/>[FR] PROMÉDICAMENT COMPRENANT UN ACIDE BÊTA-CÉTO CARBOXYLIQUE, UN SEL D'ACIDE BÊTA-CÉTO CARBOXYLIQUE OU UN ESTER D'ACIDE BÊTA-CÉTO CARBOXYLIQUE POUR L'ADMINISTRATION DE MÉDICAMENT
  申请人：YKI YTKEMISKA INST AB

  公开号：WO2010120232A1

  公开（公告）日：2010-10-21

  There is provided a prodrug of a pharmaceutically active agent, said prodrug comprising a beta-keto carboxylic acid, a beta-keto carboxylic acid salt or a beta-keto carboxylic acid ester functional group, to a pharmaceutical composition comprising the prodrug, and to the use of the prodrug or composition for treatment of a mammalian subject suffering from a condition which can be cured or alleviated by administration of said pharmaceutically active agent. There is further provided a method of inhibiting decarboxylation of a compound comprising a beta-keto carboxylic acid or a salt thereof with a monovalent cation, characterized in that a dry salt of said beta-keto carboxylic acid with a divalent or polyvalent cation is prepared.

  提供了一种药用活性剂的前药，该前药包括β-酮羧酸、β-酮羧酸盐或β-酮羧酸酯官能团，以及包括该前药的药物组合物，以及将该前药或组合物用于治疗患有可以通过给药该药用活性剂来治愈或缓解的病症的哺乳动物主体的用途。还提供了一种抑制具有β-酮羧酸或其盐的化合物的脱羧作用的方法，其特征在于制备带有二价或多价阳离子的该β-酮羧酸的干盐。
• Organic Compounds and Compositions Having the Ability to Modulate Fragrance Compositions
  申请人：Schilling Boris

  公开号：US20100111888A1

  公开（公告）日：2010-05-06

  Disclosed are compounds having the ability to modulate, namely to improve, enhance and or modify fragrance compositions due to their ability to inhibit cytochrome P450 enzymes, e.g. CYP2A13 and CYP2B6.

  本发明涉及一种化合物，其具有调节香气组合物的能力，即由于其抑制细胞色素P450酶，例如CYP2A13和CYP2B6的能力，能够改善、增强和/或修改香气组合物。